All Stories

  1. Metabolic crosstalk between organelles
  2. News and views
  3. Deficiency of the Mitochondrial NAD Kinase Causes Stress-Induced Hepatic Steatosis in Mice
  4. Changes in the Metabolome in Response to Low-Dose Exposure to Environmental Chemicals Used in Personal Care Products during Different Windows of Susceptibility
  5. In vivomouse myocardial31P MRS using three-dimensional image-selectedin vivospectroscopy (3D ISIS): technical considerations and biochemical validations
  6. Transorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolism
  7. Corrigendum
  8. Novel, Compound Heterozygous, Single-Nucleotide Variants inMARS2Associated with Developmental Delay, Poor Growth, and Sensorineural Hearing Loss
  9. Fiber-type-specific sensitivities and phenotypic adaptations to dietary fat overload differentially impact fast- versus slow-twitch muscle contractile function in C57BL/6J mice
  10. Cholesterol-Induced Hepatic Inflammation Does Not Underlie the Predisposition to Insulin Resistance in Dyslipidemic Female LDL Receptor Knockout Mice
  11. High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids
  12. Pioglitazone treatment restoresin vivomuscle oxidative capacity in a rat model of diabetes
  13. SUMOylation-Dependent LRH-1/PROX1 Interaction Promotes Atherosclerosis by Decreasing Hepatic Reverse Cholesterol Transport
  14. Bile acids alter male fertility through G-protein-coupled bile acid receptor 1 signaling pathways in mice
  15. Multilayered Genetic and Omics Dissection of Mitochondrial Activity in a Mouse Reference Population
  16. A Mitochondrial Expatriate: Nuclear Pyruvate Dehydrogenase
  17. Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism
  18. In vivo proton T1relaxation times of mouse myocardial metabolites at 9.4 T
  19. Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia
  20. Fasting Serum Taurine-Conjugated Bile Acids Are Elevated in Type 2 Diabetes and Do Not Change With Intensification of Insulin
  21. Optimizing anesthetic regimen for surgery in mice through minimization of hemodynamic, metabolic, and inflammatory perturbations
  22. Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models
  23. Aberrant protein acylation is a common observation in inborn errors of acyl-CoA metabolism
  24. Mitochondrial protein acetylation is driven by acetyl-CoA from fatty acid oxidation
  25. Identification and characterization of Eci3, a murine kidney-specific  3, 2-enoyl-CoA isomerase
  26. Muscle MRI in patients with long-chain fatty acid oxidation disorders
  27. ACAD9, a complex I assembly factor with a moonlighting function in fatty acid oxidation deficiencies
  28. Myocardial energy shortage and unmet anaplerotic needs in the fasted long-chain acyl-CoA dehydrogenase knockout mouse
  29. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient
  30. Biochemical Competition Makes Fatty-Acid β-Oxidation Vulnerable to Substrate Overload
  31. Impaired amino acid metabolism contributes to fasting-induced hypoglycemia in fatty acid oxidation defects
  32. Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism
  33. Prevention and reversal of hepatic steatosis with a high-protein diet in mice
  34. Carnitine supplementation attenuates myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice
  35. Overexpression of PLIN5 in skeletal muscle promotes oxidative gene expression and intramyocellular lipid content without compromising insulin sensitivity
  36. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines
  37. Genetic basis of hyperlysinemia
  38. Acylcarnitines
  39. Adaptive reciprocity of lipid and glucose metabolism in human short-term starvation
  40. Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure
  41. Functional redundancy of mitochondrial enoyl-CoA isomerases in the oxidation of unsaturated fatty acids
  42. Characterization of D-3-hydroxybutyrylcarnitine (ketocarnitine): an identified ketosis-induced metabolite
  43. Improving the description of metabolic networks: the TCA cycle as example
  44. Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis
  45. A Diet Rich in Unsaturated Fatty Acids Prevents Progression Toward Heart Failure in a Rabbit Model of Pressure and Volume Overload
  46. Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids
  47. Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation
  48. Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation
  49. Role of Medium- and Short-Chain L-3-Hydroxyacyl-CoA Dehydrogenase in the Regulation of Body Weight and Thermogenesis
  50. New Driver for Lipid Synthesis
  51. The metabolic footprint of aging in mice
  52. Fasting-Induced Myocardial Lipid Accumulation in Long-Chain Acyl-CoA Dehydrogenase Knockout Mice Is Accompanied by Impaired Left Ventricular Function
  53. Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats
  54. Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
  55. Post-natal myogenic and adipogenic developmental
  56. PARP-2 Regulates SIRT1 Expression and Whole-Body Energy Expenditure
  57. Critical assessment of human metabolic pathway databases: a stepping stone for future integration
  58. Acyl-CoA Dehydrogenase 9 Is Required for the Biogenesis of Oxidative Phosphorylation Complex I
  59. The Effects of Long- or Medium-Chain Fat Diets on Glucose Tolerance and Myocellular Content of Lipid Intermediates in Rats
  60. The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results
  61. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation
  62. Effect of Statins on the Viability of Macrophages and Smooth Muscle Cells
  63. Glutamine Synthetase in Muscle Is Required for Glutamine Production during Fasting and Extrahepatic Ammonia Detoxification
  64. Increased mitochondrial content rescues in vivo muscle oxidative capacity in long-term high-fat-diet-fed rats
  65. Mitochondrial long chain fatty acid β-oxidation in man and mouse
  66. Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism
  67. Muscle acylcarnitines during short-term fasting in lean healthy men
  68. Effects of Insulin on Ketogenesis Following Fasting in Lean and Obese Men
  69. Pyruvate dehydrogenase kinase 4 expression is synergistically induced by AMP-activated protein kinase and fatty acids
  70. Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-Induced Metabolic Disorders by Enhancing Fat Oxidation
  71. A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis
  72. Metabolomics: Unraveling the chemical individuality of common human diseases
  73. Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-Induced Metabolic Disorders by Enhancing Fat Oxidation
  74. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes
  75. The Glucosylceramide Synthase InhibitorN-(5-Adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin Induces Sterol Regulatory Element-Binding Protein-Regulated Gene Expression and Cholesterol Synthesis in HepG2 Cells
  76. A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine
  77. Characterization of l-aminocarnitine, an inhibitor of fatty acid oxidation
  78. Peroxisome Proliferator-activated Receptor (PPAR)-2 Controls Adipocyte Differentiation and Adipose Tissue Function through the Regulation of the Activity of the Retinoid X Receptor/PPARγ Heterodimer
  79. Compromised Intestinal Lipid Absorption in Mice with a Liver-Specific Deficiency of Liver Receptor Homolog 1
  80. In VivoImaging of Farnesoid X Receptor Activity Reveals the Ileum as the Primary Bile Acid Signaling Tissue
  81. A liver revival featuring bile acids
  82. The small heterodimer partner is a gonadal gatekeeper of sexual maturation in male mice
  83. Homing in on bile acid physiology
  84. Peroxisomes and bile acid biosynthesis
  85. Endocrine functions of bile acids
  86. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
  87. Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency
  88. PGC-1α
  89. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
  90. Peroxisome proliferator-activated receptor-γ: too much of a good thing causes harm
  91. The enterohepatic nuclear receptors are major regulators of the enterohepatic circulation of bile salts
  92. Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPARγ hypomorphic mice
  93. Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands
  94. Regulation of Isoprenoid/Cholesterol Biosynthesis in Cells from Mevalonate Kinase-deficient Patients
  95. Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept
  96. Lack of isoprenoid products raises ex vivo interleukin-1? secretion in hyperimmunoglobulinemia D and periodic fever syndrome
  97. Erratum: Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome
  98. Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome
  99. Nonorthologous Gene Displacement of Phosphomevalonate Kinase
  100. Biochemical and genetic aspects of mevalonate kinase and its deficiency
  101. Identification and Characterization of Three Novel Missense Mutations in Mevalonate Kinase cDNA Causing Mevalonic Aciduria, a Disorder of Isoprene Biosynthesis
  102. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemiaD and periodic fever syndrome